Development of a vision‐related quality of life instrument for children ages 8–18 years for use in juvenile idiopathic arthritis–associated uveitis

Abstract

Our study provides evidence of the validity and reliability of the EYE-Q in the measurement of VRQOL. The EYE-Q may complement clinical measures of visual impairment and overall QOL and become an important tool in the assessment of QOL in JIA-associated uveitis.